Although BafA1 pretreated HCC cells could not restore the decrease of the MARCH1 protein level caused by myricetin treatment, BafA1 could enhance the antiproliferative effect of myricetin in HCC cells. The gene discussed is MARCHF1; the disease is hepatocellular carcinoma.